Stasis Dermatitis When Topical Symptomatic Treatment Has Not Relieved Pruritus
This protocol applies when initial topical management of stasis dermatitis has failed to adequately control pruritus of the lower extremities, and the patient continues to experience leg pain and edema that require a different therapeutic approach.
Previous Treatment & Why It Was Not Enough
A prior course of topical symptomatic treatment — using emollients, topical corticosteroids, topical calcineurin inhibitors, or topical phosphodiesterase 4 inhibitors — did not achieve its primary goal of relieving pruritus of the lower extremities. This unmet outcome is the clinical trigger for moving to the regimen described here.
Clinical Goals at This Stage
The targets for this next-step protocol are reduction of leg pain and reduction of edema of the lower extremities.
Treatment Approach (Partial Overview)
Management shifts to oral pharmacotherapy, with agents selected to address both leg pain and lower-limb swelling. The full drug selection, sequencing, and supporting measures are detailed in the complete protocol.
References
DOI: 10.1007/s40257-022-00753-5
- Oral pentoxifylline is often used with or without compression therapy to reduce leg pain and to increase the healing rate of venous ulcers.
- Edema may be reduced through the use of venoactive drugs, which reduce capillary permeability, increase venous tone, decrease blood viscosity and improve lymphatic drainage.
- Escin, a horse chestnut seed extract that stimulates F-series prostaglandins, is used to improve symptoms of chronic venous insufficiency on a short-term basis.
- Another venoactive drug, micronized purified flavonoid fraction, was shown to be more potent than other venoactive drugs at reducing ankle edema.
- Hydroxyethylrutosides can also be utilized to relieve symptoms of chronic venous insufficiency, including pain, cramps, and a feeling of heaviness in the legs.
View source ↗